An illustration of a magnifying glass. An illustration of a magnifying glass.

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.

Speaker of the House of Commons Sir Lindsay Hoyle has made a guest appearance in Emmerdale – with some glaringly obvious dialogue. Sir Lindsay had wished to make the trip in 2022, whilst ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Zicsaloma has announced that he has done a nose surgery as he shared the journey with his fans on social media In the post, he showed how he travelled for the surgery, the place where it took place ...

Bhad Bhabie was spotted out with her friends in Los Angeles over the weekend after revealing she got a nose job. On Friday, the 21-year-old rapper, born Danielle Bregoli, went to pick up a matcha ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

The pea-size spot near the tip of his nose seemed so innocuous Ben Murray thought it might have been numb for a while and he simply hadn’t noticed. In March 2020, Murray, a videographer and ...

The heartwarming update comes just weeks after Gerrard's daughter Lilly-Ella shared the news that she's expecting her first child. The former Liverpool captain, who often gives fans a glimpse into ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...